siRNA therapy decreases triglycerides in people with unusual disorder

.INVESTIGATION EMPHASIZE.19 September 2024.

Plozasiran minimized triglyceride levels by 80% and decreased the threat of pancreatitis in patients with relentless chylomicronemia, along with or even without a hereditary diagnosis.